Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments in hematopoietic stem cell expansion

C von Kalle1, H Glimm, G Schulz

  • 1University of Freiberg, Germany.

Current Opinion in Hematology
|March 27, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

ESMO open·2026
Same author

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

ESMO gastrointestinal oncology·2026
Same author

Mismatch repair deficiency and microsatellite instability in adrenocortical carcinoma.

ESMO open·2026
Same author

CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial.

ESMO open·2025
Same author

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

ESMO open·2025
Same author

Urinary diversion and quality of life: A six-year follow-up study of bladder cancer surgery.

Actas urologicas espanolas·2025
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Ex vivo culture of human hematopoietic stem cells enables improved stem cell transplants and hematopoietic gene therapy. Advances show potential for cell maintenance, manipulation, and expansion, paving the way for graft engineering.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Gene Therapy

Background:

  • Ex vivo culture of human hematopoietic stem cells (HSCs) is crucial for improving stem cell transplantation outcomes.
  • Current limitations in HSC expansion and manipulation hinder the full potential of HSC-based therapies.
  • Advances in ex vivo HSC culture offer new possibilities for graft engineering.

Purpose of the Study:

  • To review recent developments in ex vivo culture of human hematopoietic stem cells.
  • To discuss the regulatory implications of these advancements.
  • To explore the application of ex vivo HSC expansion in hematopoietic gene therapy.

Main Methods:

  • Review of recent scientific literature on ex vivo hematopoietic stem cell culture.
  • Analysis of experimental evidence for HSC maintenance and expansion.

Related Experiment Videos

  • Assessment of regulatory considerations and therapeutic applications.

    • Main Results:

    • Experimental evidence supports the qualitative and quantitative maintenance of HSCs in ex vivo culture.
    • Potential for numerical expansion of HSCs has been demonstrated.
    • Ex vivo graft engineering is becoming a realistic possibility.

    Conclusions:

    • Ex vivo culture techniques are advancing the field of hematopoietic stem cell manipulation.
    • These advancements have significant implications for autologous and allogeneic stem cell transplants.
    • Ex vivo HSC expansion is a key enabler for hematopoietic gene therapy.